NANOTECHNOLOGY: A PATHWAY FOR SUSTAINABLE INNOVATION IN DRUG DEVELOPMENT

Here, Andrea Cusack, Chief Executive Officer, leon, discusses how, by using bottom-up nanotechnology techniques, efficiencies can be found both in the development of new chemical entities and in the repurposing of existing drugs, and how these efficiencies translate into reduced energy requirements and therefore more sustainable industry practices.

© leon-nanodrugs GmbH 2020
DisclaimerPrivacy PolicySite Notice